Skip to content
Disclosery

Vida Ventures Advisors, LLC

Follow

13F filer, CIK 1831423, BOSTON, MA

Vida Ventures Advisors, LLC reported $13,637,875 across 3 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-04-03.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0000950123-25-003299

Period
2025-03-31
Reported value
$13.6M
Holdings
3
Top 10 weight
100%
New
0
Sold out
3

Largest buys vs the previous quarter

None.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
CNTAexited-3,931,818-$65.9M
TECXexited-1,028,674-$47.5M
DYNexited-407,499-$9.6M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0000950123-25-003299, largest first. % of portfolio is the value over $13,637,875, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
KYTXKYVERNA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: not reported; 2024Q1: 4,523,924 shares; 2024Q2: 4,523,924 shares; 2024Q3: 4,523,924 shares; 2024Q4: 4,523,924 shares; 2025Q1: 4,523,924 shares 4,523,924$8.73M64.02%0Timeline
ALLOALLOGENE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 1,798,163 shares; 2024Q1: 1,798,163 shares; 2024Q2: 1,798,163 shares; 2024Q3: 1,798,163 shares; 2024Q4: 1,798,163 shares; 2025Q1: 1,798,163 shares 1,798,163$2.63M19.25%0Timeline
KRONOS BIO INCKRONOS BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: 2,765,314 shares; 2024Q1: 2,765,314 shares; 2024Q2: 2,765,314 shares; 2024Q3: 2,765,314 shares; 2024Q4: 2,765,314 shares; 2025Q1: 2,765,314 shares 2,765,314$2.28M16.73%0

Sold out in Q1 2025

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
CNTACENTESSA PHARMACEUTICALS PLC3,931,818$65.9Mshares
TECXTECTONIC THERAPEUTIC INC1,028,674$47.5Mshares
DYNDYNE THERAPEUTICS INC407,499$9.6Mshares

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0000950123-25-003299 base2025-04-03acceptance time not in the bulk data set